Skip to content

Elamipretide (SS-31) studies: 372 papers with results

Page 2 of 8

  1. Elamipretide (SS-31) improves mitochondrial dysfunction, synaptic and memory impairment induced by lipopolysaccharide in mice.

    Zhao W · Journal of neuroinflammation · 2019

    Animal study (in vivo) · mouse · 6 results

  2. ATP-binding cassette A1 deficiency causes cardiolipin-driven mitochondrial dysfunction in podocytes.

    Ducasa GM · The Journal of clinical investigation · 2019

    Animal study (in vivo) · mouse · 3 results

  3. Mitochondrial-targeted peptide rapidly improves mitochondrial energetics and skeletal muscle performance in aged mice.

    Siegel MP · Aging cell · 2013

    Animal study (in vivo) · mouse · 9 results

  4. Mitochondria Protection after Acute Ischemia Prevents Prolonged Upregulation of IL-1β and IL-18 and Arrests CKD.

    Szeto HH · Journal of the American Society of Nephrology : JASN · 2017

    Animal study (in vivo) · rat · 7 results

  5. A novel cell-permeable antioxidant peptide, SS31, attenuates ischemic brain injury by down-regulating CD36.

    Cho S · The Journal of biological chemistry · 2007

    Animal study (in vivo) · mouse · 7 results

  6. Mitochondria targeted peptides protect against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity.

    Yang L · Antioxidants & redox signaling · 2009

    Animal study (in vivo) · mouse · 6 results

  7. Cell-permeable peptide antioxidants as a novel therapeutic approach in a mouse model of amyotrophic lateral sclerosis.

    Petri S · Journal of neurochemistry · 2006

    Animal study (in vivo) · mouse · 5 results

  8. Improving mitochondrial function with SS-31 reverses age-related redox stress and improves exercise tolerance in aged mice.

    Campbell MD · Free radical biology & medicine · 2019

    Animal study (in vivo) · mouse · 9 results

  9. Enhanced efficiency of mitochondria-targeted peptide SS-31 for acute kidney injury by pH-responsive and AKI-kidney targeted nanopolyplexes.

    Liu D · Biomaterials · 2019

    Animal study (in vivo) · mouse · 7 results

  10. Reduction of ischemia/reperfusion injury with bendavia, a mitochondria-targeting cytoprotective Peptide.

    Kloner RA · Journal of the American Heart Association · 2012

    Animal study (in vivo) · rabbit and sheep · 8 results

  11. Global proteomics and pathway analysis of pressure-overload-induced heart failure and its attenuation by mitochondrial-targeted peptides.

    Dai DF · Circulation. Heart failure · 2013

    Animal study (in vivo) · 5 results

  12. Catalpol ameliorates depressive-like behaviors in CUMS mice via oxidative stress-mediated NLRP3 inflammasome and neuroinflammation.

    Wang YL · Translational psychiatry · 2021

    Animal study (in vivo) · mouse · 3 results

  13. Mitochondrial ROS regulate oxidative damage and mitophagy but not age-related muscle fiber atrophy.

    Sakellariou GK · Scientific reports · 2016

    Animal study (in vivo) · mouse · 3 results

  14. Late-life restoration of mitochondrial function reverses cardiac dysfunction in old mice.

    Chiao YA · eLife · 2020

    Animal study (in vivo) · mouse · 8 results

  15. A mitochondrial permeability transition pore inhibitor improves renal outcomes after revascularization in experimental atherosclerotic renal artery stenosis.

    Eirin A · Hypertension (Dallas, Tex. : 1979) · 2012

    Animal study (in vivo) · pig · 9 results

  16. Mitochondria-targeted peptide SS-31 attenuates renal injury via an antioxidant effect in diabetic nephropathy.

    Hou Y · American journal of physiology. Renal physiology · 2016

    Animal study (in vivo) · mouse · 29 results

  17. Mitochondrial protection restores renal function in swine atherosclerotic renovascular disease.

    Eirin A · Cardiovascular research · 2014

    Animal study (in vivo) · pig · 9 results

  18. The mitochondrial-targeted peptide, SS-31, improves glomerular architecture in mice of advanced age.

    Sweetwyne MT · Kidney international · 2017

    Animal study (in vivo) · mouse · 9 results

  19. Mitochondrial oxidative damage reprograms lipid metabolism of renal tubular epithelial cells in the diabetic kidney.

    Hou Y · Cellular and molecular life sciences : CMLS · 2024

    Animal study (in vivo) · 5 results

  20. Reduction of elevated proton leak rejuvenates mitochondria in the aged cardiomyocyte.

    Zhang H · eLife · 2020

    Animal study (in vivo) · mouse and rat · 5 results

  21. Novel cardiolipin therapeutic protects endothelial mitochondria during renal ischemia and mitigates microvascular rarefaction, inflammation, and fibrosis.

    Liu S · American journal of physiology. Renal physiology · 2014

    Animal study (in vivo) · rat · 7 results

  22. Reduction of early reperfusion injury with the mitochondria-targeting peptide bendavia.

    Brown DA · Journal of cardiovascular pharmacology and therapeutics · 2014

    Animal study (in vivo) · rabbit · 7 results

  23. Mitochondria-Targeted Peptide Reverses Mitochondrial Dysfunction and Cognitive Deficits in Sepsis-Associated Encephalopathy.

    Wu J · Molecular neurobiology · 2015

    Animal study (in vivo) · mouse · 6 results

  24. Crosstalk between autophagy and oxidative stress regulates proteolysis in the diaphragm during mechanical ventilation.

    Smuder AJ · Free radical biology & medicine · 2018

    Animal study (in vivo) · rat · 2 results

  25. Mitochondrial permeability transition in the diabetic heart: contributions of thiol redox state and mitochondrial calcium to augmented reperfusion injury.

    Sloan RC · Journal of molecular and cellular cardiology · 2012

    Animal study (in vivo) · rat · 2 results

  26. The cardiolipin-binding peptide elamipretide mitigates fragmentation of cristae networks following cardiac ischemia reperfusion in rats.

    Allen ME · Communications biology · 2020

    Animal study (in vivo) · rat · 6 results

  27. Mitochondria targeted peptide SS-31 prevent on cisplatin-induced acute kidney injury via regulating mitochondrial ROS-NLRP3 pathway.

    Yang SK · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2020

    Animal study (in vivo) · mouse · 10 results

  28. Abnormalities of Mitochondrial Dynamics in the Failing Heart: Normalization Following Long-Term Therapy with Elamipretide.

    Sabbah HN · Cardiovascular drugs and therapy · 2018

    Animal study (in vivo) · dog · 7 results

  29. Real-time imaging of mitochondrial redox reveals increased mitochondrial oxidative stress associated with amyloid β aggregates in vivo in a mouse model of Alzheimer's disease.

    Calvo-Rodriguez M · Molecular neurodegeneration · 2024

    Animal study (in vivo) · mouse · 3 results

  30. Mitochondrial targeting with antioxidant peptide SS-31 prevents mitochondrial depolarization, reduces islet cell apoptosis, increases islet cell yield, and improves posttransplantation function.

    Thomas DA · Journal of the American Society of Nephrology : JASN · 2007

    Animal study (in vivo) · mouse · 7 results

  31. SS-31 Provides Neuroprotection by Reversing Mitochondrial Dysfunction after Traumatic Brain Injury.

    Zhu Y · Oxidative medicine and cellular longevity · 2018

    Animal study (in vivo) · mouse · 12 results

  32. Doxorubicin-induced oxidative stress differentially regulates proteolytic signaling in cardiac and skeletal muscle.

    Montalvo RN · American journal of physiology. Regulatory, integrative and comparative physiology · 2020

    Animal study (in vivo) · 8 results

  33. The multi-tissue landscape of somatic mtDNA mutations indicates tissue-specific accumulation and removal in aging.

    Sanchez-Contreras M · eLife · 2023

    Animal study (in vivo) · mouse · 2 results

  34. A novel cell-permeable antioxidant peptide decreases renal tubular apoptosis and damage in unilateral ureteral obstruction.

    Mizuguchi Y · American journal of physiology. Renal physiology · 2008

    Animal study (in vivo) · 4 results

  35. Combined Therapy with SS31 and Mitochondria Mitigates Myocardial Ischemia-Reperfusion Injury in Rats.

    Lee FY · International journal of molecular sciences · 2018

    Animal study (in vivo) · rat · 18 results

  36. Restoration of Mitochondrial Cardiolipin Attenuates Cardiac Damage in Swine Renovascular Hypertension.

    Eirin A · Journal of the American Heart Association · 2016

    Animal study (in vivo) · pig · 11 results

  37. SS-31 and NMN: Two paths to improve metabolism and function in aged hearts.

    Whitson JA · Aging cell · 2020

    Animal study (in vivo) · mouse · 8 results

  38. BDNF pathway is involved in the protective effects of SS-31 on isoflurane-induced cognitive deficits in aging mice.

    Wu J · Behavioural brain research · 2016

    Animal study (in vivo) · mouse · 3 results

  39. A mitochondrial therapeutic reverses visual decline in mouse models of diabetes.

    Alam NM · Disease models & mechanisms · 2015

    Animal study (in vivo) · mouse · 3 results

  40. Bendavia restores mitochondrial energy metabolism gene expression and suppresses cardiac fibrosis in the border zone of the infarcted heart.

    Shi J · Life sciences · 2015

    Animal study (in vivo) · rat · 8 results

  41. Restoring mitochondrial superoxide levels with elamipretide (MTP-131) protects db/db mice against progression of diabetic kidney disease.

    Miyamoto S · The Journal of biological chemistry · 2020

    Animal study (in vivo) · mouse · 6 results

  42. SS31 Ameliorates Sepsis-Induced Heart Injury by Inhibiting Oxidative Stress and Inflammation.

    Liu Y · Inflammation · 2019

    Animal study (in vivo) · mouse · 16 results

  43. Targeting Mitochondria by SS-31 Ameliorates the Whole Body Energy Status in Cancer- and Chemotherapy-Induced Cachexia.

    Ballarò R · Cancers · 2021

    Animal study (in vivo) · mouse · 9 results

  44. Characterization of acute and chronic neuropathies induced by oxaliplatin in mice and differential effects of a novel mitochondria-targeted antioxidant on the neuropathies.

    Toyama S · Anesthesiology · 2014

    Animal study (in vivo) · mouse · 6 results

  45. Mitochondrial targeted peptides attenuate residual myocardial damage after reversal of experimental renovascular hypertension.

    Eirin A · Journal of hypertension · 2014

    Animal study (in vivo) · pig · 6 results

  46. SS-31 Protects Liver from Ischemia-Reperfusion Injury via Modulating Macrophage Polarization.

    Shang L · Oxidative medicine and cellular longevity · 2021

    Animal study (in vivo) · 9 results

  47. The antioxidant peptide SS31 prevents oxidative stress, downregulates CD36 and improves renal function in diabetic nephropathy.

    Hou Y · Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2018

    Animal study (in vivo) · mouse · 16 results

  48. Role of mitochondrial dysfunction in renal fibrosis promoted by hypochlorite-modified albumin in a remnant kidney model and protective effects of antioxidant peptide SS-31.

    Zhao H · European journal of pharmacology · 2017

    Animal study (in vivo) · rat · 7 results

  49. A Mitochondrion-Targeted Antioxidant Ameliorates Isoflurane-Induced Cognitive Deficits in Aging Mice.

    Wu J · PloS one · 2015

    Animal study (in vivo) · mouse · 10 results

  50. The mitochondrially targeted peptide elamipretide (SS-31) improves ADP sensitivity in aged mitochondria by increasing uptake through the adenine nucleotide translocator (ANT).

    Pharaoh G · GeroScience · 2023

    Animal study (in vivo) · 6 results

How PepBank reports evidence